Internal Medicine
| 3 min read
New research revealed that manufacturer-funded clinical trials deem drugs more effective than non-sponsored trials.
Proteomics-guided biomarker discovery unlocks new pathways to understanding, diagnosing, and treating diseases.
| 4 min read
Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.
| 3 min read
Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.
| 3 min read
New StreamlineMP software suite offers specialized data analysis modules to standardize and speed up workflows in key bioanalytical applications
| 7 min read
The link between metabolism and sleep is helping scientists find new biomarkers to detect sleepless nights and diagnose chronic sleep disorders.
| 3 min read
Gut microbes can protect or sensitize each other to drugs, even to non-antibiotics.
| 9 min read
With new tools, researchers hope to improve diagnosis of platelet dysfunction by measuring their forces.
| 6 min read
A liver enzyme affects fibrosis progression by altering metabolism of the sugar trehalose in the gut.
Mastering data preparation is key to harnessing the full potential of advanced computational tools.
| 3 min read
Nanobodies that bacteria secrete only in the presence of a biomarker treat inflammatory bowel disease at the site of inflammation.
How can researchers and laboratories best leverage digital technologies for faster drug development?
